CVS SEC Filings: 8-K, 10-Q, S-3 & 424B – CVS Health

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 5, 2026

11-K

Form 11-K - Annual report of employee stock purchase, savings and similar plans

Jun 23, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 6, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 10, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 29, 2025

News

TYPE

HEADLINE

FILED AT

8-K

CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare

Nov 4, 2026

8-K

CVS Health Reports Third Quarter 2026 Results and Raises Full-Year 2026 Guidance

Nov 4, 2026

8-K

CVS Health Announces Board of Directors Changes

Aug 17, 2026

8-K

CVS Health Reports Strong Second Quarter 2026 Results and Raises Full-Year 2026 Guidance

Aug 5, 2026

8-K

CVS Health Corporation Announces Results of 2026 Annual Meeting of Stockholders

May 18, 2026

8-K

CVS Health Reports Strong Q1 2026 Results and Raises Full-Year Guidance

May 6, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Aug 12, 2025

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Aug 11, 2025

424B2

Form 424B2 - Prospectus [Rule 424(b)(2)]

Dec 5, 2024

424B3

UPDATED

Dec 3, 2024

424B2

$5,000,000,000

May 8, 2024

424B3

13,089

May 7, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 22, 2026

S-3ASR

May 2026 SHELF

May 22, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 11, 2025

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Dec 3, 2024

S-8

Registration

May 22, 2024

FWP

$1,000,000,000 5.400% Senior Notes due 2029

May 7, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 3, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 3, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 4, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 4, 2025

PX14A6G

Form PX14A6G - Notice of exempt solicitation submitted by non-management

Apr 16, 2024

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 5, 2024

Ownerships

TYPE

HEADLINE

FILED AT

Shah Prem S (Reporting)

Nov 6, 2026

13F-HR

Form 13F-HR - Quarterly report filed by institutional managers, Holdings

Nov 5, 2026

SCHEDULE 13G/A

DODGE & COX (Filed by)

Aug 13, 2026

13F-HR

Form 13F-HR - Quarterly report filed by institutional managers, Holdings

Aug 6, 2026

Clark James David (Reporting)

Jun 29, 2026

Newman Brian (Reporting)

Jun 1, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Nov 21, 2024

CORRESP

Form CORRESP - Correspondence

Nov 21, 2024

LETTER

Form UPLOAD - SEC-generated letter

Nov 19, 2024

LETTER

Form UPLOAD - SEC-generated letter

May 15, 2023

CORRESP

Form CORRESP - Correspondence

May 15, 2023

LETTER

Form UPLOAD - SEC-generated letter

May 11, 2023

CVS Health Corp. CVS · SEC Filings